The addition of rotavirus vaccine to the list of funded vaccines will have a long-lasting positive effect on children’s health, says PHARMAC Medical Director Dr John Wyeth.
New Zealanders have gained greater access to medicines in 2013, and record numbers of New Zealanders received funded medicines in the past year.
PHARMAC is seeking public feedback on changes to the national immunisation schedule - including the addition of vaccines for rotavirus and varicella.
PHARMAC is seeking further input from the public as it decides how to apply its existing approach to managing hospital medical devices.
PHARMAC has secured the national supply of influenza vaccines for the next three years.
PHARMAC is providing greater funded access to the expensive enzyme replacement therapy imiglucerase (Cerezyme), mainly expanding its use in children.
An outstanding calibre of applications has seen the Hiwinui Heke pharmacy scholarships shared among four Māori pharmacy students this year.
The change to new blood glucose testing meters has been completed, with more than 100,000 people picking up the new meters.
The national hospitals pharmaceutical list (HML) has been published for the first time on 1 July 2013. This brings nationally consistent access to subsidised pharmaceuticals into DHB hospitals.
PHARMAC has released new guidance for health professionals, consumers and clinicians to make it easier for them to apply for pharmaceuticals to be funded.
PHARMAC has taken a further major step towards forming a national list of hospital medicines that will be available nationwide.
PHARMAC is welcoming the appointment of Porirua-based general practitioner Sean Hanna to the Pharmacology and Therapeutics Advisory Committee (PTAC).
A free whooping cough vaccine will be available to all pregnant women from 1 January 2013 to help protect their new-born babies from this serious disease.
PHARMAC steps up to help meet Government cancer treatment goal.
Recent decisions by PHARMAC will have a positive effect on cancer treatment in New Zealand.
People with diabetes are being reminded about changes to blood glucose testing meters and testing strips.
From 1 December PHARMAC will stop funding meters other than the three meters from the CareSens range.
PHARMAC asking: How do we get the best advice for our medical devices work?
PHARMAC has released a consultation document seeking the views of clinicians. It asks how PHARMAC should make decisions on medical devices, when the agency takes over management of them in 2015.
PHARMAC is to fund new combination HIV medicines from 1 December. Atripla and Truvada are both combination pills for the treatment of people with HIV. Atripla...
PHARMAC welcomes new Pharmacology and Therapeutics Advisory Committee (PTAC) chair